A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Safety and Efficacy of Topiramate in the Treatment of Tourette Syndrome (CAPSS-176)

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Safety and Efficacy of Topiramate in the Treatment of Tourette Syndrome (CAPSS-176)

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2017

At a glance

  • Drugs Topiramate (Primary)
  • Indications Gilles de la Tourette's syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jan 2010 Results were published in the Journal of Neurology, Neurosurgery and Psychiatry.
    • 07 Jun 2009 Results published as an abstract in the proceedings of the 13th International Congress of Parkinson's Disease and Movement Disorders.
    • 05 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top